HOME › DRUGS › LECANEMAB
ACTIVE SUBSTANCE / INN

LECANEMAB

Brand name(s): Leqembi
EMA LISTED
AUTHORISED
Cognitive Dysfunction;Alzheimer Disease
ACTIVE SUBSTANCE
Lecanemab
REGULATORS
EMA
SPONSORS / MAH
Eisai GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LeqembiEisai GmbHAuthorised15/04/2025Cognitive Dysfunction;Alzheimer Disease

FULL INTELLIGENCE ON LECANEMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →